Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

21/05/2018
Prime Minister Theresa May has said that the application of artificial intelligence and other technologies to the NHS could help to save more than 20,000 cancer deaths a year by 2033.
21/05/2018
The UK’s biggest care home provider is on the market with its owners seeking around £1 billion from the sale, according to the FT.
18/05/2018
Australian technology company Alcidion Group has bought UK-based Patientrack for an undisclosed sum.
18/05/2018
Not-for-profit care village operator Belong has opened a new dementia care village in the market town of Newcastle-under-Lyme in Staffordshire.
18/05/2018
August Equity-backed Dental Partners has grown with the acquisition of Dentapol to 27 clinics.


Civica



Christie + Co

my images



M&A

With more and more health and social care companies split up into opco-propco models, Ploy Radford asks if we're about to see a spate of opco-only deals - and what should buyers beware of
Read more



elderly care

With city dwellers increasingly looking to stay put as they age, Sarah Williams investigates how prepared the UK is to meet urban demand
Read more



HealthInvestor blog
The health and social care sector needs to embrace gender diversity after disappointing pay gap results

Click here to view the Editor's blog


Northamptonshire County Council has declared itself bankrupt. Ryan Perrott and Clare Connell of Connell Consulting ask what does this actually mean for social care?
Pure Sports Medicine was established after its founder was disappointed with the UK’s offering for musculoskeletal injuries. Ploy Radford investigates how the provider has addressed a gap in the market
Local authority funding is a mixed bag geographically and the causes of funding cuts are not all the same. Kayleigh Hartigan, managing director of Marwood Group, advises on the issues providers should be mindful of
With city dwellers increasingly looking to stay put as they age, Sarah Williams investigates how prepared the UK is to meet urban demand
With more and more health and social care companies split up into opco-propco models, Ploy Radford asks if we’re about to see a spate of opco-only deals – and what should buyers beware of

Click here to search all feature articles